These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17023005)

  • 1. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling.
    Oishi Y; Ozono R; Yoshizumi M; Akishita M; Horiuchi M; Oshima T
    Life Sci; 2006 Dec; 80(1):82-8. PubMed ID: 17023005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
    Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarction.
    Matsusaka H; Kinugawa S; Ide T; Matsushima S; Shiomi T; Kubota T; Sunagawa K; Tsutsui H
    J Cardiovasc Pharmacol; 2006 Sep; 48(3):95-102. PubMed ID: 17031262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 4th communication: improvement of heart failure of rats with myocardial infarction by valasartan.
    Hayashi N; Fujimura Y; Yamamoto S; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):625-9. PubMed ID: 9205776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
    Jugdutt BI; Menon V
    Mol Cell Biochem; 2004 May; 260(1-2):111-8. PubMed ID: 15228092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On angiotensin II receptor distribution after myocardial infarction in dogs].
    Qu XF; Li JJ; Xi Y; Shen JX; Xiu CH; Yue L; Wang GZ; Huang YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):358-62. PubMed ID: 19791474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice.
    Higashikuni Y; Takaoka M; Iwata H; Tanaka K; Hirata Y; Nagai R; Sata M
    Hypertens Res; 2012 Jan; 35(1):62-9. PubMed ID: 21833001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the early administration of losartan on the functional and morphological aspects of postmyocardial infarction ventricular remodeling in rabbits.
    González GE; Palleiro J; Monroy S; Pérez S; Rodríguez M; Masucci A; Gelpi RJ; Morales C
    Cardiovasc Pathol; 2005; 14(2):88-95. PubMed ID: 15780800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
    Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
    Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation].
    Miki T; Miura T; Tsuchida A; Nakano A; Hasegawa T; Fukuma T; Shimamoto K
    J Cardiol; 2001 Feb; 37(2):112-3. PubMed ID: 11255694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling.
    Villarreal FJ; Griffin M; Omens J; Dillmann W; Nguyen J; Covell J
    Circulation; 2003 Sep; 108(12):1487-92. PubMed ID: 12952845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin AT2 receptor deficiency after myocardial infarction: its effects on cardiac function and fibrosis depend on the stimulus.
    Tschöpe C; Westermann D; Dhayat N; Dhayat S; Altmann C; Steendijk P; Schultheiss HP; Walther T
    Cell Biochem Biophys; 2005; 43(1):45-52. PubMed ID: 16043882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of peroxisome proliferator-activated receptor gamma ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction.
    Geng DF; Wu W; Jin DM; Wang JF; Wu YM
    Int J Cardiol; 2006 Oct; 113(1):86-91. PubMed ID: 16891009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats.
    Nakamura R; Kato J; Kitamura K; Onitsuka H; Imamura T; Cao Y; Marutsuka K; Asada Y; Kangawa K; Eto T
    Circulation; 2004 Jul; 110(4):426-31. PubMed ID: 15262849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
    Kassab S; Garadah T; Abu-Hijleh M; Golbahar J; Senok S; Wazir J; Gumaa K
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):206-11. PubMed ID: 17318789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice.
    Xu J; Carretero OA; Liu YH; Shesely EG; Yang F; Kapke A; Yang XP
    Hypertension; 2002 Sep; 40(3):244-50. PubMed ID: 12215461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats.
    Liang Q; Elson AC; Gerdes AM
    J Card Fail; 2006 Aug; 12(6):479-86. PubMed ID: 16911916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.
    Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Esaki M; Kanamori H; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
    J Card Fail; 2007 Mar; 13(2):155-62. PubMed ID: 17395057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.